News
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The agency says it is now set to only recommend Covid vaccines to older adults, those over 65 years old, and people who are ...
The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results